Reverse Merges in Biotech | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Reverse Merges in Biotech

An SI Board Since June 2007

Posts	SubjectMarks	Bans
5	4	0

Emcee: rkrw	Type: Moderated

Introduction Compact

Place to keep track of biotech reverse mergers. Post when announced and when available for trading. Some solid and not so solid biotechs have come public this route.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
5	By my calculation, and I could be wrong, there will be 16.5 million common share	Glenn Petersen	-	6/13/2007
4	The stock (BVIC.OB) closed at $5.25 yesterday, though only 500 shares changed ha	Glenn Petersen	-	6/13/2007
3	Athersys. I have no idea how many shares are outstanding. It won't become tr	rkrw	-	6/11/2007
2	Could be way off, but that looks like 26.5m c/s outstanding, plus warrants, once	keokalani'nui	-	6/11/2007
1	Athersys. Round completed at $5/share. Press Release Source: Athersys, Inc.	rkrw	-	6/11/2007

Go to reply# or date (mm/dd/yy):